|
Based on the available information, this event is deemed to be a reportable malfunction.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number.Reporting site: 1049092.Manufacturing site: 3005778470.
|
|
Additional information - this emdr is being submitted to include the below: h6: investigation results under type of investigation, investigation findings, investigation conclusions.H11: investigation summary.Based on the available information, this event is deemed to be a reportable malfunction.No photo has been received for this complaint.A batch record review indicates no discrepancies.Ileostomy bags in question were manufactured under international commodity code (icc), system application product (sap) material identification (id) 1737576 and manufacturing lot #5f04195.Order (b)(4) was produced in june 2025 on machine a221, with lot amount (b)(4) pcs.The production process, in-process control, testing result, packaging of products was run according to the process instruction (pi) for esteembody drainable pouches and recorded in batch record (br) instruction.During production were used collars system application product (sap) 1737393 - convex baseplate flex v1 ctf 10-45 mm, lot 5f01073 and 5d05569.Collars were produced in accordance with process instruction (pi) pi pre baseplate na k55/mme2 and all measuring and control are recorded in batch record (br) instruction.During production of product lot 5f04195 were used all the right components.Review of the device history record (dhr) showed that all relevant tests required during manufacturing process and final product release had been fulfilled and met the requirements.No nonconformance has been registered during the manufacturing process of the affected lot and of the mention issue.No similar complaints related to ¿pouch materials in contact with skin are too rough or sharp¿ was received on mentioned lot 5f04195.No samples, photograph or relevant objective evidence has been received for this complaint.Affected quantity is 1 pc / lot size (b)(4) pcs, which represent (b)(4).We can not perform deeper investigation without relevant objectives evidence.No additional action is required, and this complaint will be closed.This issue will be monitored through the post market product monitoring review process, standard operating procedure (sop).To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number: reporting site: 1049092.Manufacturing site: 3005778470.
|